Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1 5Phase 4 2Phase 1/2 2Phase NA 1Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Myeloid 1Gastrointestinal 1

Conditions

Mastocytosis, Systemic 1Gastrointestinal Stromal Tumors 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Interventional × avapritinib × Clear all
NCT06748001 2026-02-09

Avapritinib Rollover Study

Blueprint Medicines Corporation

Phase 4 Recruiting
60 enrolled
Myeloid

Mastocytosis, Systemic

NCT04825574 2024-11-26

Study for Patients Previously Treated in Avapritinib Clinical Trials

Blueprint Medicines Corporation

Phase 4 Completed
2 enrolled 4 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡